| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.00044 | 1 |